There have been conflicting reports on the benefits of statins (HMG CoA reductase inhibitors) in patients with Alzheimer’s disease and the importance of cholesterol biosynthesis in the pathophysiology of AD.
Neurology
Mitoxantrone in MS: AAN report
August 18, 2010The AAN Therapeutics and Technology Assessment subcommittee has published its report on the safety and efficacy of mitoxantrone in multiple sclerosis, concluding that the risks of systolic dysfunction and therapy-related leukemia are higher than previously estimated (Marriott et al. Neurology 2010; 74: 1463-1470; free full text at www.neurology.org/cgi/reprint/74/18/1463).
Two negative trials of lithium in ALS
July 21, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – In 2008, Italian researchers reported that lithium 300-450 mg/day delayed disease progression in amyotrophic lateral sclerosis (Fornai et al. PNAS 2008; 105: 2052-2057; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC2538879/?tool=pubmed).
Troponin in intracerebral hemorrhage
July 21, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – Several retrospective analyses have suggested that elevated troponin levels at admission are associated with higher mortality rates in patients following intracerebral hemorrhage (ICH) (Garrett et al. Neurocrit Care 2010; 12: 199-203; Hays & Diringer. Neurology 2006; 66: 1330-1334; Chung et al. J Korean Neurosurg Soc 2009; 45: 355-359. Free full text at www.jkns.or.kr/htm/fulltext.asp?no=0042009075).
Trichloroethylene associated with PD risk
July 7, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – A population-based study reports that trichloroethylene exposure is a risk factor for the develop of Parkinson’s disease (Goldman et al. AAN, S03.005).